Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carbapenem Resistant Enterobacteriaceae Infection”

56 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 56 results

Not applicableStudy completedNCT03924934
What this trial is testing

Community-associated Highly-Resistant Enterobacterales

Who this might be right for
Enterobacteriaceae InfectionsCommunity-Acquired InfectionsHealthcare Associated Infection+1 more
University of North Carolina, Chapel Hill 2,172
Not applicableNot Yet RecruitingNCT06210542
What this trial is testing

Precise Treatment of Ceftazidime-Avibactam in Patients With CRO Infections Under the Guidance of TDM and PPK Model

Who this might be right for
ECMOCarbapenem-Resistant Enterobacteriaceae Infection
Sichuan Provincial People's Hospital 50
Not applicableStudy completedNCT01266499
What this trial is testing

A Study Evaluating the Role of Oral Antibiotics in an Aim to Eradicate Carrier State of Carbapenem- Resistant Klebsiella Pneumonia (KPC).

Who this might be right for
Klebsiella Pneumoniae Carbapenemase Resistant Associated Bacteremia or Pneumonia
Rambam Health Care Campus 200
Not applicableStudy completedNCT04583098
What this trial is testing

The Effect of Fecal Microbiota Transplantation on the Decolonization of Multidrug-resistant Organisms

Who this might be right for
Carbapenem-Resistant Enterobacteriaceae InfectionVancomycin-Resistant Enterococcal Infection
Chuncheon Sacred Heart Hospital 100
Not applicableUnknownNCT05850871
What this trial is testing

Drug Resistance Mechanism of Enterobacteriaceae and Its Strategies

Who this might be right for
Carbapenem-Resistant Enterobacteriaceae Infection
Qianfoshan Hospital 427
Large-scale testing (Phase 3)Looking for participantsNCT07089186
What this trial is testing

Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infections

Who this might be right for
Hospital-acquired Bacterial Pneumonia (HABP)Ventilator-associated Bacterial Pneumonia (VABP)Complicated Intra-abdominal Infection (cIAI)+2 more
Qilu Pharmaceutical Co., Ltd. 80
Testing effectiveness (Phase 2)Looking for participantsNCT04759001
What this trial is testing

FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae

Who this might be right for
Enterobacteriaceae InfectionsMulti-antibiotic Resistance
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 52
Not applicableStudy completedNCT07172932
What this trial is testing

ANTIBIOTIC-RESISTANT ENTEROBACTERALES BLOODSTREAM INFECTIONS AND RISK FACTORS IN PATIENTS ADMITTED TO THE INTENSIVE CARE UNIT

Who this might be right for
Bloodstream InfectionsEnterobacteriaceae InfectionsIntensive Care (ICU)+1 more
Ankara City Hospital Bilkent 314
Post-approval studies (Phase 4)Looking for participantsNCT05979545
What this trial is testing

EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics

Who this might be right for
Blood Stream InfectionsVentilator Associated PneumoniaHealthcare Associated Infection+2 more
National University of Singapore 1,900
Not applicableLooking for participantsNCT07086391
What this trial is testing

Different Methods of Aerosolized Polymyxin B Inhalation for Treating Carbapenem-Resistant Gram-Negative Bacterial Pneumonia.

Who this might be right for
Carbapenem-Resistant Enterobacteriaceae InfectionPneumonia - Bacterial
Fujian Medical University Union Hospital 144
Post-approval studies (Phase 4)WithdrawnNCT04785924
What this trial is testing

Imipenem/Cilastatin/Relebactam (IMI/REL) in Treatment of CRE Infections

Who this might be right for
Carbapenem-Resistant Enterobacteriaceae InfectionKPCGram-Negative Bacterial Infections+1 more
Wake Forest University Health Sciences
Early research (Phase 1)Ended earlyNCT02922816
What this trial is testing

FMT for MDRO Colonization After Infection in Renal Transplant Recipients

Who this might be right for
Infection Due to Resistant Organism
Emory University 11
Not applicableUnknownNCT05981430
What this trial is testing

Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant Enterobacteriaceae

Who this might be right for
Carbapenem-Resistant Enterobacteriaceae InfectionFecal Microbiota Transplantation
The University of Hong Kong 80
Not applicableStudy completedNCT02482051
What this trial is testing

Ultra Rapid Culture Independent Detection of High-Priority Carbapenem Resistant Enterobacteriaceae Directly From Blood

Who this might be right for
BacteremiaEnterobacteriaceae Infections
Denver Health and Hospital Authority 100
Not applicableStudy completedNCT04167228
What this trial is testing

Impact of Ceftazidime / Avibactam Treatment vs Better Available Therapy on Mortality of Patients With Infections Caused by Carbapenem-resistant Enterobacteria

Who this might be right for
Carbapenem-Resistant Enterobacteriaceae Infection
Maimónides Biomedical Research Institute of Córdoba 348
Large-scale testing (Phase 3)Study completedNCT01970371
What this trial is testing

Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE)

Who this might be right for
Bloodstream Infections (BSI) Due to CREHospital-Acquired Bacterial Pneumonia (HABP) Due to CREVentilator-Associated Bacterial Pneumonia (VABP) Due to CRE+2 more
Achaogen, Inc. 69
Not applicableUnknownNCT06049771
What this trial is testing

The Population Pharmacokinetics Study of Tigecycline and Pharmacokinetics- Pharmacodynamics Index in Patients With Carbapenem Resistant Enterobacteriaceae Bloodstream Infection

Who this might be right for
Carbapenem-resistant Enterobacteriaceae
Phramongkutklao College of Medicine and Hospital 72
Large-scale testing (Phase 3)Ended earlyNCT04876430
What this trial is testing

Best Available Therapy With or Without Meropenem for Bloodstream Infections by Enterobacterales With High Level of Resistance to Carbapenems

Who this might be right for
Carbapenem-Resistant Enterobacteriaceae InfectionBloodstream Infection
Hospital de Clinicas de Porto Alegre 13
Large-scale testing (Phase 3)Study completedNCT02168946
What this trial is testing

Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults

Who this might be right for
Urinary Tract Infection ComplicatedAcute PyelonephritisHospital Acquired Bacterial Pneumonia+3 more
Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) 77
Not applicableStudy completedNCT05413772
What this trial is testing

Temocillin in ESBL-Enterobacteriaceae Infections

Who this might be right for
Infectious Disease
Assistance Publique - Hôpitaux de Paris 29
Load More Results